PTGS2 and Alzheimer disease: Upregulation of iNOS and the associated increase in NO production, along with enhanced expression of COX-2, have been linked to the advancement of AD pathology (O'banion, 1999; Xiang et al., 2002; Medeiros et al., 2007).